Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City

• Published in: The Journal of infectious diseases Vol. 222; no. Supplement_5; pp. S322 - S334
• Main Authors: Jordan, Ashly E, Cleland, Charles M, Wyka, Katarzyna, Schackman, Bruce R, Perlman, David C, Nash, Denis
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 02.09.2020
• Subjects: Adolescent; Adult; Aged; Drug addiction; Drug dosages; Epidemiology; Female; Gender; Geographical variations; Hepacivirus - isolation & purification; Hepatitis; Hepatitis C; Hepatitis C - diagnosis; Hepatitis C - epidemiology; Hepatitis C - transmission; Hepatitis C - virology; Humans; Incidence; Injection; Male; Methadone; Methadone - therapeutic use; Middle Aged; Narcotics; New York City - epidemiology; Opiate Substitution Treatment - statistics & numerical data; Opioid Epidemic - statistics & numerical data; Opioid-Related Disorders - complications; Opioid-Related Disorders - epidemiology; Opioid-Related Disorders - rehabilitation; Opioids; Retrospective Studies; Seroconversion; Substance use disorder; Supplement; Viral Load; Young Adult; New York City; United States > US; New York City New York; opioid use disorder; epidemiology; epidemics; geographic analysis; hepatitis C virus; people who use drugs; HCV incidence; injection drug use

Abstract Background Hepatitis C virus (HCV) incidence has increased in the worsening opioid epidemic. We examined the HCV preventive efficacy of medication-assisted treatment (MAT), and geographic variation in HCV community viral load (CVL) and its association with HCV incidence. Methods HCV inciden...